Research Search Results

This randomized phase III trial studies how well doxorubicin hydrochloride & cyclophosphamide work in treating patients with triple-negative breast cancer.

Status: Active, Recruiting

This randomized phase 3 trial studies how well cisplatin or carboplatin works compared to observation in treating patients following chemotherapy after surgery.

Status: Active, Recruiting

Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

Status: Active, Recruiting

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence).

Status: Active, Recruiting

This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas.

Status: Active, Recruiting

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor (LXR).

Status: Active, Recruiting

The purpose of this study s to collect additional safety and efficacy data for the combination of ribociclib + letrozole in men and pre/postmenopausal women...

Status: Active, Recruiting

This trial studies how well cisplatin works with or without veliparib in treating patients with stage IV triple-negative breast cancer.

Status: Active, Recruiting

This trial studies how well aspirin works in preventing recurrence in patients with HER2 breast cancer after chemotherapy, surgery, and/or radiation therapy.

Status: Active, Recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery.

Status: Active, Recruiting